<--- Back to Details
First PageDocument Content
Anti-acne preparations / Amides / Clindamycin / Bacterial diseases / Pharmaceutical industry / Bioequivalence / Staphylococcus aureus / Capsule / Bacteria / Medicine / Pharmacology
Anti-acne preparations
Amides
Clindamycin
Bacterial diseases
Pharmaceutical industry
Bioequivalence
Staphylococcus aureus
Capsule
Bacteria
Medicine
Pharmacology

Microsoft Word[removed]298foi.doc

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 151,13 KB

Share Document on Facebook

Similar Documents

Original Research Article In vitro evaluation of antibacterial activity of verbascoside, lemon verbena extract and caffeine in combination with gentamicin against drugresistant Staphylococcus aureus and Escherichia coli

DocID: 1v3Be - View Document

Exercise (a) Find the gene fdh in Staphylococcus aureus subsp. aureus N315. How many orthologues does it have? (b) Find the human orthologue. What is the target %id and the query %id? Why are these different?

DocID: 1uZaI - View Document

Original article | Published 15 September 2016, doi:smwCite this as: Swiss Med Wkly. 2016;146:w14339 Staphylococcus aureus and methicillin resistance in Switzerland: regional differences and trends fr

DocID: 1uR3v - View Document

COMMENT ON “ Evidence for the Absence of Staphylococcus aureus in the Land Applied Biosolids.” Rusin et al. (1 and in ref 2) dismissed processed sewage sludges as a source of Staphylococcus aureus infections a

DocID: 1utHY - View Document

Review articles Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe R Köck1,2, K Becker2, B Cookson3, J E van Gemert-Pijnen4 , S Harbarth5,6, J Kluytmans7,8, M Mielke9

DocID: 1sz5k - View Document